Alembic receives USFDA approval for Leflunomide drug

Alembic has got an approval of US Food and Drug Administration (USFDA) for the generic version of arthritis drug Leflunomide. The approval is for 10 mg and 20 mg strengths of Leflunomide tablets.

Leflunomide is prescribed in active, moderate, and severe rheumatoid arthritis and psoriatic arthritis and is sold by French pharmaceutical major Sanofi-Aventis under the brand name Arava.

Alembic is a leading pharmaceutical company in India. The company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates.